Navigation Links
Cephalon Receives FDA Approval for TREANDA, a Novel Chemotherapy for Chronic Lymphocytic Leukemia
Date:3/20/2008

- First New Agent for CLL Patients Approved by the FDA since 2001 -

FRAZER, Pa., March 20 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) today announced that the U.S. Food and Drug Administration (FDA) has approved TREANDA(R) (bendamustine hydrochloride) for Injection for the treatment of patients with chronic lymphocytic leukemia (CLL), a slowly progressing blood and bone marrow disease. The American Cancer Society estimates that more than 15,000 new cases of this rare disease will be diagnosed in the United States this year. The TREANDA application as a CLL treatment received priority review from the FDA and was approved within six months of the September 2007 submission. Cephalon anticipates that TREANDA will be available to physicians and patients as a CLL treatment in the United States in April 2008.

To view the Multimedia News Release, go to:

http://www.prnewswire.com/mnr/treanda/32349/.

"TREANDA is an important new treatment for patients with chronic lymphocytic leukemia, and this first-cycle approval by FDA represents a significant milestone in the growth of our oncology business," said Dr. Lesley Russell, Executive Vice President, Worldwide Medical and Regulatory Operations. "With a strong pipeline of near- and longer-term opportunities, Cephalon Oncology is poised to deliver therapies that target both hematologic cancers and solid tumors for patients in need of new options."

Dr. Bruce Cheson, Clinical Professor of Hematology/Oncology, Georgetown University School of Medicine, Washington D.C., stated, "Patients with chronic lymphocytic leukemia can often live normal lives for many years because of treatments that control the disease over the long-term. TREANDA is an effective new option that offers a delay in disease progression, an important goal for patients with chronic lymphocytic leukemia."

In a randomized, international, m
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Cephalon Statement on Federal Trade Commission Action Regarding PROVIGIL Patent Settlements
2. Cephalons 2007 Results Exceed Full Year Sales and Earnings Guidance
3. Cephalon General Counsel John E. Osborn to Resign Position
4. Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application
5. Cephalons EFFENTORA Receives Positive Opinion from European Regulatory Authorities for the Management of Breakthrough Cancer Pain
6. Cephalon Presentation Slides for the 26th Annual JPMorgan Healthcare Conference Now Available
7. Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkins Lymphoma
8. Cephalon Submits Supplemental New Drug Application for FENTORA
9. Cephalon Announces Strong Third Quarter Financial Results
10. Cephalon Quarterly Conference Call Invitation
11. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2009)... United Kingdom, Dec. 10 Newly ... East England Stem Cell Institute (NESCI) in ... successful treatment of eight patients with "Limbal ... own stem cells without the need of ... http://www.newscom.com/cgi-bin/prnh/20080422/CLTU133LOGO-a ) ,, LSCD is a painful, ...
(Date:12/10/2009)... Dec. 10 /PRNewswire-Asia-FirstCall/ -- China Biologic,Products, Inc. (Nasdaq: ... one of the,leading plasma-based biopharmaceutical companies in China, ... ring the opening bell at the,NASDAQ MarketSite in ... Tuesday, December 15,2009. , ... NASDAQ Global Market on,December 2, 2009, under the ...
(Date:12/10/2009)... Biomatrica, the leader in room temperature ... SampleWare 3.1 software system for laboratory inventory, organization ... now includes an audit trail functionality that tracks ... complete history of any stored sample. ,, ... customers a much needed ability to track all ...
(Date:12/10/2009)... to Create Optimized Antibodies Produces First Candidates ... , MISSISSAUGA, ON, Dec. 10 /PRNewswire-FirstCall/ - ... announced the first results of a collaborative ... Research Council of Canada,s Biotechnology Research ... program is designed to generate novel antibodies ...
Breaking Biology Technology:Successful Stem Cell Therapy for Treatment of Eye Disease 2Successful Stem Cell Therapy for Treatment of Eye Disease 3Successful Stem Cell Therapy for Treatment of Eye Disease 4China Biologic Products to Ring NASDAQ Opening Bell 2China Biologic Products to Ring NASDAQ Opening Bell 3Biomatrica Launches SampleWare 3.1 2Biomatrica Launches SampleWare 3.1 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 2YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 4YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 5
... method for testing the quality of a sperm before ... of conception. , Researchers at the University of Edinburgh, ... Council), have created a way of chemically ,fingerprinting, individual ... then consider whether the sperm is healthy enough to ...
... Cell Biosciences, Inc., a,provider of nanoproteomic analysis systems ... its first kits for the analysis of specific,oncoproteins ... new kits are,optimized for characterization of proteins in ... in cancer cell survival and proliferation. Drug developers,have ...
... NOIDA, India, Jan. 21 Jubilant Organosys Ltd,headquartered ... its subsidiary,Jubilant Biosys Ltd., based in Bangalore, has ... will further enable the process of,high throughput screening, ... launched in the US and Europe initially, allows ...
Other Biology Technology:New sperm shaker to improve IVF success 2Cell Biosciences Introduces Kits for Oncoprotein Analysis 2Jubilant Biosys Launches Legend NGSS(TM) Advanced Software Solution for High-Throughput Drug Molecule Screening 2
(Date:12/11/2009)... ORFruit growers, profits have traditionally been limited ... where growing seasons can be short. Thanks ... varieties are being introduced that offer growers ... offseasonresulting in economic bonuses for both producers ... varieties of blackberry called "primocane-fruiting", which bear ...
(Date:12/11/2009)... It is common knowledge that smoking is a health ... more easily than adults? In an evaluation for Faculty ... are more prone to substance abuse. , Grunberg describes ... Synapse journal, as "fascinating" and suggests it "may ... prone to drug abuse". , Nicotine increases the level ...
(Date:12/11/2009)... hake, lumpsucker and salmon is the best dietary source of ... at the University of Almera (UAL). The scientists analysed the ... of these contained high levels of these fatty acids, which ... had been no precise understanding of the nutritional potential of ... from the UAL has now shown that this is one ...
Breaking Biology News(10 mins):New management methods extend blackberry season 2Roe of marine animals is best natural source of omega-3 2CPF Announces Dates for Seventh Annual National Pulmonary Fibrosis Awareness Week 50102 1CPF Announces Dates for Seventh Annual National Pulmonary Fibrosis Awareness Week 50102 2CPF Announces Dates for Seventh Annual National Pulmonary Fibrosis Awareness Week 50102 3CPF Announces Dates for Seventh Annual National Pulmonary Fibrosis Awareness Week 50102 4The Time To Rethink Male Circumcision Is Now Group Says In Launching www intactamerica org 50097 1The Time To Rethink Male Circumcision Is Now Group Says In Launching www intactamerica org 50097 2The Time To Rethink Male Circumcision Is Now Group Says In Launching www intactamerica org 50097 3The Time To Rethink Male Circumcision Is Now Group Says In Launching www intactamerica org 50097 410 students receive scholarships for outstanding work in public health systems research 50092 1
... characteristics in certain deadly brain tumors that make them ... class of drugs than tumors in which the molecular ... molecular signature ?the expression of a mutant protein and ... ?will allow researchers to identify patients who are likely ...
... is seen as a hero by his cancer-stricken neighbor, "D.H." ... lung cancer. , "In 2000 he was told by his ... Pardini, a professor of biochemistry and associate director of the ... "But five years later, he is still alive, and ...
... consumers in Asia have received a little good news just ... remain deadlocked on how to move ahead with agricultural reforms ... research just published has confirmed details of a proven strategy ... China and India. , The research shows that, in 1999, ...
Other Biology News:UCLA discovery will aid in treatment of patients with a deadly brain cancer 2UCLA discovery will aid in treatment of patients with a deadly brain cancer 3The nude mouse tale: Omega-3 fats save the life of a terminal cancer patient 2Some good news for the world's poor 2Some good news for the world's poor 3Some good news for the world's poor 4